Moat Investing

Moat Investing

Sign-up to Receive
Our Latest Insights

MOAT
VanEck Vectors Morningstar US Wide Moat UCITS ETF

Fund Description: VanEck Vectors Morningstar US Wide Moat UCITS ETF is a UCITS-compliant exchange-traded fund (ETF) that invests in a portfolio of equity securities. The ETF aims to provide investment returns that closely track the price and yield performance of the Morningstar® Wide Moat Focus IndexTM.

Index Description: The Morningstar Wide Moat Focus Index tracks the overall performance of attractively priced US companies with sustainable competitive advantages according to Morningstar’s equity research team. The rules-based index is reviewed quarterly. Please consult http://indexes.morningstar.com for detailed index information.

Management Style: Replication

 
 

  • Fund Ticker

    MOAT
  • Management Company

    VanEck Investments Ltd.
  • Custodian

    BNY Mellon Trust Company (Ireland) Limited
  • Domicile

    Ireland
  • UCITS Compliant

    YES
  • Index Ticker

    MWMFTR
  • Index Provider

    Morningstar
  • Rebalance Frequency

    Semi-Annually, Staggered quarterly
  • Inception Date2

    16 Oct 2015
1The "Net Asset Value" (NAV) of all ETFs is determined at the close of each business day, and represents the value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF 's intraday trading value. Investors should not expect to buy or sell ETF shares at NAV.

2The date the fund was launched prior to quotation on the stock exchange.

 
as of 19 Aug 2019

  • NAV1

    34.36
  • Shares Outstanding

    3,750,000
  • Number of Holdings

    52
  • Base Currency

    USD
  • Net Assets

    $128.9M
  • Product Structure

    Physical (Full Replication)
  • Distribution Frequency

    None
  • Income Treatment

    Reinvestment
  • Total Expense Ratio

    0.49%
  • Fact Sheet
  • ETF Product List

All Holdings (%) Download All Holdings as of 19 Aug 2019

Total Holdings: 52
Holding Name
Ticker
Shares Market Value
(US$)
% of Net
Assets
Kla Corp
KLAC US
27,169
3,813,441 2.96
Kellogg Co
K US
57,199
3,685,332 2.86
Applied Materials Inc
AMAT US
77,735
3,661,319 2.84
Facebook Inc
FB US
18,962
3,530,156 2.74
Zimmer Biomet Holdings Inc
ZBH US
25,002
3,464,277 2.69
General Mills Inc
GIS US
62,685
3,460,212 2.69
Comcast Corp
CMCSA US
78,536
3,455,584 2.68
General Dynamics Corp
GD US
18,257
3,424,831 2.66
Western Union Co/The
WU US
159,840
3,418,978 2.65
Philip Morris International Inc
PM US
39,712
3,375,917 2.62
Campbell Soup Co
CPB US
77,122
3,330,899 2.59
Microchip Technology Inc
MCHP US
36,800
3,313,840 2.57
T Rowe Price Group Inc
TROW US
29,906
3,278,296 2.54
Medtronic Plc
MDT US
31,114
3,241,457 2.52
Guidewire Software Inc
GWRE US
34,205
3,239,556 2.51
Dominion Energy Inc
D US
41,379
3,218,872 2.50
Amazon.Com Inc
AMZN US
1,769
3,212,716 2.49
Gilead Sciences Inc
GILD US
47,223
3,027,467 2.35
Blackrock Inc
BLK US
7,093
3,018,497 2.34
Wells Fargo & Co
WFC US
66,403
3,004,736 2.33
Intel Corp
INTC US
61,808
2,919,192 2.27
Salesforce.Com Inc
CRM US
20,284
2,914,202 2.26
Compass Minerals International Inc
CMP US
56,190
2,890,976 2.24
Emerson Electric Co
EMR US
49,051
2,871,936 2.23
Caterpillar Inc
CAT US
23,750
2,787,300 2.16
Charles Schwab Corp/The
SCHW US
72,651
2,738,943 2.13
Biogen Inc
BIIB US
11,530
2,717,852 2.11
State Street Corp
STT US
53,167
2,705,669 2.10
Hershey Co/The
HSY US
13,231
2,087,455 1.62
Allergan Plc
AGN US
11,917
1,897,782 1.47
Blackbaud Inc
BLKB US
19,755
1,878,701 1.46
Walt Disney Co/The
DIS US
13,605
1,840,620 1.43
Amgen Inc
AMGN US
8,908
1,835,048 1.42
Microsoft Corp
MSFT US
13,209
1,828,258 1.42
Mcdonald's Corp
MCD US
8,245
1,803,841 1.40
Mckesson Corp
MCK US
12,293
1,794,286 1.39
Alphabet Inc
GOOGL US
1,450
1,740,638 1.35
Mondelez International Inc
MDLZ US
31,486
1,717,876 1.33
United Technologies Corp
UTX US
12,607
1,596,550 1.24
Raytheon Co
RTN US
8,837
1,583,502 1.23
Amerisourcebergen Corp
ABC US
17,848
1,566,162 1.22
Unitedhealth Group Inc
UNH US
6,397
1,565,410 1.21
Bristol-Myers Squibb Co
BMY US
32,840
1,558,586 1.21
Nike Inc
NKE US
18,930
1,535,791 1.19
Cheniere Energy Inc
LNG US
24,075
1,474,594 1.14
Harley-Davidson Inc
HOG US
45,273
1,474,089 1.14
Polaris Inc
PII US
17,544
1,440,362 1.12
John Wiley & Sons Inc
JW/A US
32,486
1,407,618 1.09
Cardinal Health Inc
CAH US
31,842
1,384,490 1.07
Jones Lang Lasalle Inc
JLL US
9,769
1,319,694 1.02
Core Laboratories Nv
CLB US
32,304
1,297,329 1.01
Pfizer Inc
PFE US
36,217
1,274,114 0.99
Other/Cash
--
--
229,238 0.18
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

This website is for informational/advertisement purposes only.

Information contained in this website does not constitute any legal or investment advice. This website does not constitute an offer to sell or solicitation to buy any security, including shares of any investment fund promoted on this website and other financial instrument, products or services sponsored by VanEck Investments Limited, Think ETF Asset Management B.V. (“Think ETF’s”) or other VanEck affiliates (together “VanEck”).

VanEck constructs and issues the investment funds but does not give any financial advice to private investors or accept client funds. VanEck provides financial services (e.g. financial advice) only to professional clients according to the detailed definition in the Terms and Conditions of this website. For questions regarding investing or trading please contact your advisor, brokerage or bank. If you have technical questions regarding our investment funds, please contact us.

An investment in the promoted investment funds may only be made based on the investment fund’s official sales prospectus, the relevant supplement and KIID and will be subject to the terms and conditions contained therein.

You can lose money by investing in the Funds. The value of the investments may go up or down and the investor may not get back the amount invested. Past performance is not a guide to future performance and should not be the sole factor of consideration when selecting a product. Any investment in a fund should be part of an overall investment program, not a complete program. An investor should consider investment objectives, risks, charges, and expenses of the investment carefully before investing.

Investment fund investing involves risk, including possible loss of principal. Investors should consult the prospectus and key investor information document (“KIID”) before subscribing to any fund. The prospectus, the key investor information documents and the financial reports can be obtained free of charge from this website and upon request from the funds’ registered office and the offices of all local information agents. The documents, except for KIIDs, are only available in English and Swiss German and for ETFs issued by Think ETF’s also in Dutch.

Performance quoted represents past performance. Current performance may be lower or higher than average annual returns shown. Discrete performance shows 12 month performance to the most recent Quarter end for each of the last 5yrs where available. E.g. '1st year' shows the most recent of these 12-month periods and '2nd year' shows the previous 12 month period and so on. Performance data is displayed on a Net Asset Value basis, in Base Currency terms, with net income reinvested, net of fees. Brokerage or transaction fees will apply. Investment return and the principal value of an investment will fluctuate. Shares may be worth more or less than their original cost when redeemed.

The sales prospectus and KIID contain this and other information. Please read the sales prospectus and KIID carefully before investing.

Not Insured — No Bank Guarantee — May Lose Value